Correlation Between AVROBIO and Royalty Pharma

Can any of the company-specific risk be diversified away by investing in both AVROBIO and Royalty Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AVROBIO and Royalty Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between AVROBIO and Royalty Pharma Plc, you can compare the effects of market volatilities on AVROBIO and Royalty Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AVROBIO with a short position of Royalty Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of AVROBIO and Royalty Pharma.

Diversification Opportunities for AVROBIO and Royalty Pharma

-0.64

Correlation Coefficient

AVROBIO  Royalty Pharma

Excellent diversification

The 3 months correlation between AVROBIO and Royalty is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding AVROBIO and Royalty Pharma Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Royalty Pharma Plc and AVROBIO is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AVROBIO are associated (or correlated) with Royalty Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Royalty Pharma Plc has no effect on the direction of AVROBIO i.e., AVROBIO and Royalty Pharma go up and down completely randomly.

Pair Corralation between AVROBIO and Royalty Pharma

If you would invest  140.00  in AVROBIO on September 27, 2024 and sell it today you would earn a total of  0.00  from holding AVROBIO or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	1.59%
Values	Daily Returns

AVROBIO  vs.  Royalty Pharma Plc

AVROBIO

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AVROBIO has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, AVROBIO is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Royalty Pharma Plc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Royalty Pharma Plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with AVROBIO and Royalty Pharma

The main advantage of trading using opposite AVROBIO and Royalty Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AVROBIO position performs unexpectedly, Royalty Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Royalty Pharma will offset losses from the drop in Royalty Pharma's long position.

The idea behind AVROBIO and Royalty Pharma Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.